Online Program

328813
Translating Legal and Policy Evidence and Data for Health Impact: The Healthy People 2020 Law and Health Policy Project


Monday, November 2, 2015 : 2:30 p.m. - 2:50 p.m.

Tiffani Mulder, MPH, Office of Disease Prevention and Health Promotion (CDC Assignee), Department of Health and Human Services, Rockville, MD

Angela McGowan, JD, MPH, Office of Disease Prevention and Health Promotion (CDC Assignee), Department of Health and Human Services, Rockville, MD
Lisa Caucci, JD, Office for State, Tribal, Local, and Territorial Support, Public Health Law Program, Centers for Disease Control and Prevention (CDC), Atlanta, GA
For a health in all policies approach to flourish, collaborations must occur between various sectors and all relevant tools and strategies must be considered, including legal and policy tools and perspectives.  A new effort to demonstrate the impact that law and policy have on health incorporates the broad focus of the national Healthy People 2020 (HP2020) initiative, aims to contribute to this knowledge. HP2020 provides science-based national objectives for a decade to improve the health of all Americans. The goal is to: encourage collaborations across communities and sectors; empower individuals toward making informed health decisions; and measure the impact of prevention activities.

To demonstrate the impact and effect that laws and policies can have on health, the HP2020 Law and Health Policy Project was created. This project, a partnership between the U.S. Department of Health and Human Services, the Robert Wood Johnson Foundation, the Centers for Disease Control and Prevention and CDC Foundation, will produce 10-15 evidence-based reports that showcase a broad vision of health and share how legal and policy interventions/strategies are effective tools in meeting HP2020 measureable, science-based objectives. Each report will feature progress toward national HP2020 objectives, include policy surveillance information, focus on state and local laws, and highlight evidence-based laws or case studies with demonstrated health outcomes. This presentation will explain the development process for this project, preview lessons from the first reports on diverse health-related topics, and explain their expected value for leaders taking a broad perspective on improving the health of their communities.

Learning Areas:

Planning of health education strategies, interventions, and programs
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Public health or related research

Learning Objectives:
Describe the HP2020 Law and Health Policy Project and how law and policy are tools in improving the health of the nation and promoting a health in all policies approach. Explain how evidence, including legal and policy surveillance information, can be resources to describe the impact and reach of laws, as well as how variations in policy can impact health. Provide practical information about the use of law and policy as tools to address health factors related to HP2020 topic area objectives. Discuss legal and policy surveillance information to provide more evidence about the impact and reach of laws, as well as how variations in policy can impact health.

Keyword(s): Public Health Policy, Evidence-Based Practice

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Tiffani (Mulder) Kigenyi, MPH, is a Public Health Analyst in HHS’ Office of Disease Prevention and Health Promotion (ODPHP). She serves as co-lead on the Healthy People 2020 Law and Health Policy Project. Prior to her current assignment, Tiffani served as a Project Officer and completed a graduate fellowship at CDC. She has a Bachelor’s of Science Degree in Health Science and a Masters of Public Health Degree in Health Education, Maternal and Child Health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.